No Barrier Raises $2.7M Seed to Expand AI-Powered Real-Time Medical Interpretation Platform
No Barrier, a San Francisco‑based healthcare technology startup focused on breaking down language barriers in clinical settings, has raised $2.7 million in a Seed funding round to expand its AI‑powered real‑time medical interpretation platform across the United States. The oversubscribed financing, announced in November 2025, underscores the growing investor interest in AI tools tailored to healthcare communication challenges, especially for patients with limited English proficiency.
The Seed round was led by A Squared Ventures and Esplanade Ventures, with additional participation from Rock Health and Fusion VC. Together, these investors bring deep expertise in early‑stage healthcare, digital health, and AI‑enabled enterprise solutions, signaling confidence in No Barrier’s mission and its technology’s ability to improve patient outcomes and provider efficiencies.
Founded in 2023 by CEO Eyal Heldenberg, COO Moe Abramovitch, and CTO Tomer Baum, No Barrier is building a HIPAA‑ and SOC 2‑compliant platform that delivers instantaneous, clinically validated interpretation services directly within clinician workflows. The goal is to ensure that language does not impede quality healthcare delivery, particularly for the more than 25 million people in the United States who have limited English proficiency. The platform supports real-time interpretation in 40+ languages and dialects, covering every step of the patient journey from check‑in and triage to diagnosis, treatment planning, and discharge.
No Barrier’s technology is designed to integrate seamlessly with existing electronic health record (EHR) systems and clinical processes, enabling providers to replace or augment traditional interpreter models — which are often costly, time‑consuming, and limited in availability — with an AI‑driven solution that produces zero‑wait interpretation. Early deployments of the technology have already taken place at more than 100 healthcare sites across 12 states, including facilities that span mental health, reproductive care, pediatrics, and infectious disease settings.
Healthcare systems using No Barrier’s platform have reported significant operational and clinical benefits, including the elimination of wait times for interpretation, reductions in interpretation costs of up to 70 percent, increased patient satisfaction, and lower cognitive burden on clinicians during interactions with patients who speak different languages. By embedding interpretation directly into clinical engagements, No Barrier aims to improve both patient safety and care quality, particularly in high‑stakes or complex clinical encounters.
The fresh capital from the Seed round will be used to accelerate No Barrier’s deployment across additional points of care and broader geographic markets. The company plans to scale its platform’s reach into more health systems and clinics, deepen integrations with clinical software and workflows, and continue enhancing its language models and real‑time interpretation algorithms. This strategy reflects a broader vision of eliminating language as a barrier to equitable healthcare access and ensuring consistent, accurate communication between providers and patients in every clinical setting.
Investor interest in No Barrier comes amid a rising awareness within healthcare leadership of the risks and disparities associated with inadequate language access. Studies and healthcare reports have highlighted how miscommunication between patients and providers can lead to delayed diagnoses, increased readmissions, and gaps in care quality. No Barrier’s AI‑driven solution positions itself as a scalable technology that addresses these challenges while adhering to strict privacy and security standards required in clinical environments.
The founding team’s extensive background in voice AI and speech‑to‑speech technology has been a key driver of No Barrier’s early momentum. By adapting decades of research and engineering expertise to healthcare’s unique compliance and operational needs, the company is translating advanced machine learning and natural language processing capabilities into practical, mission‑critical tools for hospitals and clinics.
As No Barrier continues to scale its operations and expand its market footprint, the company aims to further demonstrate the value of AI in promoting health equity and improving communication between providers and diverse patient populations. With strong backing from seasoned investors and early traction in real‑world clinical deployments, the $2.7 million Seed round sets the stage for No Barrier’s next phase of growth and impact in healthcare communication technology.
